MCV replication has been demonstrated in human foreskin grafted to athymic mice (Buller et al., 1995) . MCV infection is common in children, sexually transmitted between adults and is frequently seen in immunocompromised individuals (Cotton et al., 1987) . In contrast to most poxviruses, the MCV genome has a high G + C content (66%). Restriction endonudease analysis of the MCV genome shows no similarity to other poxviruses and there is considerable variability in restriction enzyme maps between three MCV subtypes (Porter & Archard, 1992) . The genome has inverted terminal repeats (Porter & Archard, 1987; Bugert et al., 1989) containing tandemly repeated sequences . Initial sequencing studies on MCV type I (MCV-I) identified an open reading flame (ORF) potentially encoding a 43 kDa protein, homologous to the vaccinia virus (VV) major envelope antigen (Blake et al., 1991) . Further studies identified a number of ORFs potentially encoding limited homology to W proteins Hadasch et al., 1993) and apparent MCV homologues of the VV genes encoding poly(A) polymerase and small (22 kDa) and large (147 kDa) subunits of the DNAdependent RNA polymerase (Sonntag et al., 1995) . The latter occur within BamHI fragment A of MCV-I DNA and their arrangement is co-linear with the equivalent VV locus.
We now report the sequence of four widely spaced regions of the MCV-I genome and the identification of putative MCV genes by comparison to the VV genomic sequence (Goebel et al., 1990; Johnson et al., 1993) .
MCV-I was purified from human skin lesions and virus DNA extracted as described by Porter & Archard (1987) . The HindlII, BamHI and C/aI restriction enzyme maps of MCV-I DNA are described by Porter & Archard (1992) . HindIII fragments Q, C, E, I, JL, N, M, H, K R and Jl~ were eluted from agarose gels and cloned in the HindlII site of plasmid pUC1318 (Kay & McPherson, I987) by standard methods. The recombinant HindIII C plasmid was digested with BamHI and sub- fragments were recloned to give clones of MCV-I BamHI fragments M, N and L. Genomic MCV-I DNA was digested with ClaI and cloned randomly in the ClaI site of Bluescript KS(+) (Stratagene): recombinant plasmids containing C/aI fragments F, H and E were isolated. Each cloned MCV-I fragment was sequenced using commercially available pUC forward and reverse primers with the PRISM Ready Reaction DyeDeoxy Terminator Cycle sequencing kit and the Applied Biosystems model 373A DNA sequencing system. ORFs were identified using DNA Strider 1.2 and potential protein homologies were identified using BLAST searches. Sequences of interest were extended by custom primer walking or sequencing appropriate subclones with pUC forward and reverse primers. The sequences reported here were determined in both directions. Where sequences spanned two adjacent cloned fragments such as BamHI L and N, HindllI ] and E or HindlII N and M, primers were designed to span the restriction sites. PCR sequencing using genomic DNA for the HindlI1 I and E or HindlII N and M junctions and a plasmid containing the HindlII C fragment including the BamHI L and N junction (see Fig. 1 ) confirmed that these fragments were indeed contiguous within the MCV genome. Repetitive sequencing in both directions revealed no ambiguities.
Four regions of MCV-I DNA totalling 7765 bp were sequenced ( Fig. I ) and analysis of these revealed marked similarity between MCV and W at the amino acid level. These regions of MCV-I DNA correspond to VV ORFs F9L, F10L, L3L to J3R, A28L-30L and A44L which include the VV genes known to code for protein kinase 2 (FIOL), structural protein VP8 (L4R), RNA polymerase 35 kDa subunit (A29L) and the 3fl-hydroxysteroid dehydrogenase (3fl-HSD) (A44L : Goebel et al., 1990; Johnson et al., 1993) . The sequences of the expanded regions of Fig. 1 are shown in Fig. 2 . The 1850 bp MCV sequence shown in Fig. 2 (a) comprises the entire BamHI N fragment plus 251 bp of the left end of BamHI M and reads from right to left in the genome. A complete ORF of 1329 bp (CX1) is present in position 110--1438, encoding a putative protein of 443 amino acids (aa) which shows 60"2 % identity and 80"5 % similarity to VV protein kinase 2 (VVPK2). The catalytic domains I, II and VI of VVPK2 (Lin & Broyles, 1994) are conserved in the putative MCV protein sequence (Fig. 3 a) , suggesting that a protein expressed from this ORF would have kinase activity. A partial ORF (CX1) extending from position 1422-1850 shows 44"4 % identity and 72"2 % similarity at the amino acid level to W ORF F9L.
The 3158 bp sequence at the right end of the centrally located MCV-I ClaI F fragment is shown in Fig. 2(b) . This contains three complete ORFs of 762 bp (CX4), 438 bp (CXS) and 549 bp (CX6) and two partial ORFs of 88 bp (CX3) and 863 bp (CX7). These MCV ORFs correspond to VV genes L3L-J3R (Goebel et al., 1990) , with the exception of the thymidine kinase (TK) gene, J2R, not found at this position in MCV-]. The complete ORFs code for putative polypeptides of 254 (CX4), 146 (CXS) and 183 (CX6) aa, resembling the products of VV ORFs L4R (42"8 % identity; 75"3 % similarity), LSR (31"8% identity; 60"6% similarity) and JIR (44"5% identity; 74"2% similarity) respectively.
The partial 863 bp ORF (CX7) shows 57"2 % aa identity and 80"7% aa similarity to VV J3R. VV ORF L4R encodes the structural protein VP8 (Yang ei aL, 1988) and W J3R encodes the poly(A) polymerase stimulatory subunit (Gershon et al., 1991) . The VV TK gene is located between ORFs JIR and J3R (Hruby & Ball, 1982) but an MCV-I homologue was not found in the corresponding location. Thymidine kinase activity has not been demonstrated in MCV and it is not known whether this gene is absent or situated in a different position in the MCV-I genome. Fowlpox virus (FPV) also lacks a TK gene in this position (Drillien et al., I987) but it has been located in the region corresponding to VV I4L (Binns et al., 1992) . which is 44"9 % identical and 75"4 % similar to that of W ORF Ad0L. CX9 encodes a putative 303 aa protein which shows 44"5 % identity and 69"5 % similarity to the RNA polymerase 35 kDa subunit encoded by VV A29L (Amegadzie et al., 199I) . Downstream of the MCV-I homologue of A29L is the start of ORF CX8 at position 1206, which shows 66"7% identity to W ORF A28L over the first 15 aa. (CXll) encoding a putative product of 354 aa which is 44% identical and 70"3 % similar to VV 3fl-HSD, the product of VV ORF A44L (Moore & Smith, 1992) . This MCV-I ORF is in the opposite orientation to the W gene and a sequence to the left of CXlI (data not shown) is similar to VV A45R, which is located to the right of VV A44L.
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Analysis of the sequences 5' to MCV ORFs reveals motifs consistent with known poxvirus early and late promoters (Davison & Moss, 1989a, b) which are conspicuous amongst the G-FC-rich coding regions of MCV. Elements with homology to VV early promoters were present upstream of ORFs CX9 and CXII and the W late motif TAAAT was present upstream of ORFs CX1-7 and CXI0 (see Fig. 2 ). It has yet to be determined whether these motifs are active in transcription of MCV genes.
These results demonstrate collinearity in gene organization between MCV-I and W in the region between VV ORFs FgL and A45R. Seven complete MCV-I ORFs have been identified which, when translated, would show 32--60% aa identity and 61-81% aa similarity to their respective VV homologues (see Fig. 3 ). Such a high degree of protein conservation in two viruses which do not cross-react serologically and which have genomes of disparate base composition implies the conservation of functions essential to poxvirus infectivity, such as the kinase, structural protein and RNA polymerase subunit. Conservation of a potential virulence factor, the 3fl-HSD, thought to reduce host inflammatory response by inducing host steroid hormone synthesis (Moore & Smith, 1992) *** *** ** * * * ** * ** ** * ** * * * * ******** * *•***~•*****
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• particularly interesting. A 3#-HSD gene has also been reported in FPV (Skinner et al., 1994) and its presence in three distinct genera suggests a fundamental role for this enzyme in poxvirus replication in vivo.
MCV has a restricted host range and cell tropism and is less pathogenic than the orthopoxviruses. Genes responsible for host range and pathogenicity are generally located near the termini of poxvirus genomes and sequencing of MCV terminal regions (Bugert et aI., 1993 , and our unpublished data for HindlII fragments C, H and K) indicates that the terminal regions of MCV and VV differ considerably in coding potential, suggesting that the determinants of restricted host range and limited pathogenicity of MCV are located there.
The development of a system to culture MCV will aid the functional analysis of these putative MCV proteins and may reveal the presence of novel and biologically interesting genes in this unusual virus.
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